FDA Warning Letter To Teva Highlights Need For Accurate Root Cause Investigations

Teva left it for US FDA to link dissolution failures to errant laser drilling of extended-release tablets. Warning letter underscores importance of timely, accurate root cause investigations.

Pharmaceutical industry man worker in protective clothing operating production of tablets in sterile working conditions - Image

More from Manufacturing

More from Compliance